Skip to main content

Jack Spinks

Head of Investor Relations

Jazz Pharmaceuticals plc (JAZZ)

Head of Investor Relations

Zymeworks Inc. (ZYME)

Equibles does not estimate personal net worth.

Get an email with a short summary when Jazz Pharmaceuticals plc publishes a filing, an earnings call transcript or a press release.

Get JAZZ alerts

About Jack Spinks

Jack Spinks is recorded as Head of Investor Relations at Jazz Pharmaceuticals plc (JAZZ) and Head of Investor Relations at Zymeworks Inc. (ZYME). Jack Spinks has spoken on 6 earnings calls and 1 other investor event across 2 companies, most recently for Jazz Pharmaceuticals plc on May 19, 2026. Those appearances were for Zymeworks Inc. (ZYME) and Jazz Pharmaceuticals plc (JAZZ). Zymeworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Jazz Pharmaceuticals plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Zymeworks Inc. includes Ali Tehrani (CEO), Kenneth Galbraith (CEO and CFO), Kristin Stafford (CFO) and 7 others.

Jack Spinks on recent calls

“And I think commercially, Leo, you know, we're really happy that we have the triplet OS, which was positive, you know, in the data readout in earlier this year.”
Head of Investor Relations, 2026 RBCCM Global Healthcare Conference ·
“Today, Jazz Pharmaceuticals reported its third quarter 2025 financial results. The slide presentation accompanying this webcast is available on the Investors section of our website.”
Head of Investor Relations, Jazz Pharmaceuticals plc Q3 FY2025 Earnings Call ·
“Today we will discuss our first quarter financial results, as well as provide an update to our ongoing business.”
Head of Investor Relations, Zymeworks Inc. Q1 FY2023 Earnings Call ·
“Today, we will discuss our fourth quarter and full year 2022 financial results, as well as provide an update to our ongoing business.”
Head of Investor Relations, Zymeworks Inc. Q4 FY2022 Earnings Call ·
“Today, we will discuss our third quarter 2022 financial results, as well as provide an update on our ongoing business.”
Head of Investor Relations, Zymeworks Inc. Q3 FY2022 Earnings Call ·

Affiliation history

Company network

Leadership on record at Zymeworks Inc.

Leadership on record at Jazz Pharmaceuticals plc

Recent activity